2025-08-01 2026-07-31 false No description of principal activity Acting Office - Tax and Accounts 1.0 12780556 bus:FullAccounts 2025-08-01 2026-07-31 12780556 bus:Micro-entities 2025-08-01 2026-07-31 12780556 bus:AuditExempt-NoAccountantsReport 2025-08-01 2026-07-31 12780556 bus:SmallCompaniesRegimeForAccounts 2025-08-01 2026-07-31 12780556 bus:PrivateLimitedCompanyLtd 2025-08-01 2026-07-31 12780556 2025-08-01 2026-07-31 12780556 2026-07-31 12780556 bus:RegisteredOffice 2025-08-01 2026-07-31 12780556 core:WithinOneYear 2026-07-31 12780556 core:AfterOneYear 2026-07-31 12780556 2024-08-01 12780556 bus:Director1 2025-08-01 2026-07-31 12780556 bus:Director1 2026-07-31 12780556 bus:Director1 2024-08-01 2025-07-31 12780556 bus:CompanySecretary1 2025-08-01 2026-07-31 12780556 bus:LeadAgentIfApplicable 2025-08-01 2026-07-31 12780556 2024-08-01 2025-07-31 12780556 2025-07-31 12780556 core:WithinOneYear 2025-07-31 12780556 core:AfterOneYear 2025-07-31 12780556 bus:EntityAccountantsOrAuditors 2024-08-01 2025-07-31 12780556 core:PatentsTrademarksLicencesConcessionsSimilar 2025-08-01 2026-07-31 12780556 core:PatentsTrademarksLicencesConcessionsSimilar 2026-07-31 12780556 core:PatentsTrademarksLicencesConcessionsSimilar 2025-07-31 12780556 core:CostValuation core:Non-currentFinancialInstruments 2026-07-31 12780556 core:CostValuation core:Non-currentFinancialInstruments 2025-07-31 12780556 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-07-31 12780556 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-07-31 12780556 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-07-31 12780556 core:ShareProfitOrLossIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-07-31 12780556 core:ProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2026-07-31 12780556 core:ImpairmentReversalProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2026-07-31 12780556 core:ForeignExchangeDifferencesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-07-31 12780556 core:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-07-31 12780556 core:TransfersBetweenInvestmentClassesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-07-31 12780556 core:Non-currentFinancialInstruments 2026-07-31 12780556 core:Non-currentFinancialInstruments 2025-07-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 12780556
England and Wales

 

 

 


Unaudited Financial Statements

for the year ended 31 July 2026

for

TEARAPY LIMITED

 
 
 
£
2026
£
   
£
2025
£
Fixed assets 89  111 
Current assets 201  717 
Creditors: amount falling due within one year (20,716) (20,716)
Net current assets/(liabilities) (20,515) (19,999)
Total assets less current liabilities (20,426) (19,888)
Net assets/(liabilities) (20,426) (19,888)
 
Capital and reserves (20,426) (19,888)
 



Notes to the Accounts
Statutory Information
Tearapy Limited is a private limited company, limited by shares, domiciled in England and Wales, registration number 12780556, registration address Flat 20 Moonstone Court, Dashwood Avenue, High Wycombe, HP12 3FG, England.

The presentation currency is £ sterling.
1.

Accounting Policies

Basis of accounting
The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).
2.

Average number of employees

Average number of employees during the year was 1 (2025: 1).

Director's Responsibilities:
  1. For the year ended 31 July 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
  2. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions.

Signed on behalf of the board of directors:


---------------------------------------------
Robert Laszlo
Director

Date approved: 18 August 2026
1